We are live on ! Find out more
Simplex Trading

Simplex Trading Portfolio holdings

AUM $149B
1-Year Est. Return 62.07%
 

Simplex Trading, founded in 2004 and headquartered in Chicago, Illinois, is a technology-driven proprietary trading firm specializing in market-making and liquidity provision, primarily in U.S. equity options and futures options. Leveraging advanced proprietary software and data-driven analysis, the firm optimizes trading strategies and develops innovative solutions to capitalize on financial market opportunities, maintaining a competitive edge through automation and a collaborative team of technologists and traders. With a workforce exceeding 300 and led by CEO Erik Swanson since 2014, Simplex operates with a low-ego, high-intelligence culture, focusing on minimal bureaucracy and rapid execution, while also making strategic venture capital investments in fintech startups. Recognized as a top workplace in Chicago by Built In’s 2025 awards, Simplex continues to evolve, blending cutting-edge technology with a commitment to market efficiency and growth.

This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
+62.07%
3 Year Est. Return
+116.86%
5 Year Est. Return
+116.02%
10 Year Est. Return
+774.44%
AUM
$179B
AUM Growth
+$8.24B
Cap. Flow
+$1.08B
Cap. Flow %
0.6%
Top 10 Hldgs %
48.72%
Holding
10,008
New
1,520
Increased
3,222
Reduced
3,616
Closed
1,504

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$133M
2
PDD icon
Pinduoduo
PDD
+$82.6M
3
BA icon
Boeing
BA
+$49.8M
4
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$45.1M
5
MSFT icon
Microsoft
MSFT
+$41M

Sector Composition

Rank Sector Weight
1 Technology 0.68%
2 Consumer Discretionary 0.23%
3 Healthcare 0.19%
4 Financials 0.13%
5 Communication Services 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STR
7651
PUT
DELISTED
Sitio Royalties
STR
$5K ﹤0.01%
300
-2,500
-89% -$55.8K
STRO icon
7652
PUT
Sutro Biopharma
STRO
$398M
$5K ﹤0.01%
320
+60
+23% +$1.83K
SUPN icon
7653
Supernus Pharmaceuticals
SUPN
$2.73B
$5K ﹤0.01%
+150
New +$5.28K
TDUP icon
7654
CALL
ThredUp
TDUP
$756M
$5K ﹤0.01%
4,100
+1,000
+32% +$1.12K
TFIN icon
7655
Triumph Financial Inc
TFIN
$1.8B
$5K ﹤0.01%
+66
New +$6.14K
TIXT
7656
CALL
DELISTED
TELUS International
TIXT
$5K ﹤0.01%
1,300
-15,000
-92% -$56.8K
TMP icon
7657
Tompkins Financial
TMP
$1.43B
$5K ﹤0.01%
+85
New +$5.89K
TNL icon
7658
PUT
Travel + Leisure Co
TNL
$4.68B
$5K ﹤0.01%
100
TSE
7659
PUT
DELISTED
Trinseo
TSE
$5K ﹤0.01%
1,100
-500
-31% -$2.47K
TURN
7660
CALL
DELISTED
180 Degree Capital
TURN
$5K ﹤0.01%
1,400
-300
-18% -$1.03K
URGN icon
7661
PUT
UroGen Pharma
URGN
$2.02B
$5K ﹤0.01%
500
-32,500
-98% -$389K
UST icon
7662
ProShares Ultra 7-10 Year Treasury
UST
$15.8M
$5K ﹤0.01%
126
-309
-71% -$13.2K
VONG icon
7663
Vanguard Russell 1000 Growth ETF
VONG
$42.3B
$5K ﹤0.01%
+57
New +$5.77K
VOR icon
7664
Vor Biopharma
VOR
$1.05B
$5K ﹤0.01%
228
-25
-10% -$414
VRCA icon
7665
Verrica Pharmaceuticals
VRCA
$91.9M
$5K ﹤0.01%
732
+489
+201% +$5.38K
WEST icon
7666
PUT
Westrock Coffee
WEST
$769M
$5K ﹤0.01%
800
+600
+300% +$4.12K
WPP icon
7667
PUT
WPP
WPP
$4.21B
$5K ﹤0.01%
100
-100
-50% -$5.28K
WRAP icon
7668
CALL
Wrap Technologies
WRAP
$99.8M
$5K ﹤0.01%
2,800
-19,100
-87% -$31.4K
XBIT icon
7669
CALL
XBiotech
XBIT
$68.9M
$5K ﹤0.01%
+1,400
New +$9.54K
ZDGE icon
7670
CALL
Zedge
ZDGE
$38.7M
$5K ﹤0.01%
+2,100
New +$6.11K
ZIMV
7671
DELISTED
ZimVie
ZIMV
$5K ﹤0.01%
390
-6,994
-95% -$100K
ZNTL icon
7672
PUT
Zentalis Pharmaceuticals
ZNTL
$321M
$5K ﹤0.01%
1,800
-20,500
-92% -$67.2K
ZYME icon
7673
CALL
Zymeworks
ZYME
$1.69B
$5K ﹤0.01%
400
-1,000
-71% -$14K
SPYQ
7674
Tradr 2X Long SPY Quarterly ETF
SPYQ
$14M
$5K ﹤0.01%
+40
New +$5.22K
KLC
7675
CALL
KinderCare Learning Companies
KLC
$603M
$5K ﹤0.01%
+300
New +$7.19K

Similar funds

Simplex Trading's Q4 2024 Portfolio in Review

As of Q4 2024, Simplex Trading held 10,008 positions worth $179B, up 4.8% from $170B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Simplex Trading's Q4 2024 filing shows 1,520 new, 3,222 increased, 3,616 reduced and 1,504 closed positions. Its largest new stake was Strategy Inc: 285,022 shares worth $82.5M. The largest sale was NVIDIA, an estimated $133M.

By sector, the portfolio is most concentrated in Technology at 0.68% of assets, up from 0.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Simplex Trading's largest Q4 2024 buy was Strategy Inc: 285,022 shares worth $82.5M.
  • Simplex Trading added most to Apple in Q4 2024, an estimated $552M increase.
  • Simplex Trading's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $133M.
  • Simplex Trading fully exited Pinduoduo in Q4 2024, selling an estimated $82.6M.
  • Simplex Trading's ten largest holdings make up 49% of its $179B portfolio in Q4 2024.
  • Simplex Trading opened 1,520 new positions and closed 1,504 in Q4 2024.
  • Simplex Trading's portfolio value rose 4.8% quarter-over-quarter to $179B.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.